MedTrace Logo

Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease

NCT00790543 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1813

Last updated 2021-11-16

No results posted yet for this study

Summary

The purpose of this study for children with a new diagnosis of Crohn's disease is to identify biomarkers found in the blood or stool to help predict which children are at risk of developing complications.

Conditions

Sponsors & Collaborators

  • Crohn's and Colitis Foundation

    collaborator OTHER

  • Emory University

    lead OTHER

Principal Investigators

  • Subra Kugathasan, MD · Emory University

Eligibility

Min Age
5 Days
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00790543 on ClinicalTrials.gov